Funder
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Puttarajappa CM, Schinstock CA, Wu CM, Leca N, Kumar V, Vasudev BS, et al. KDOQI US Commentary on the 2020 KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Am J Kidney Dis. 2021;77:833–56. http://www.ncbi.nlm.nih.gov/pubmed/33745779.
2. Jouve T, Noble J, Rostaing L, Malvezzi P. Tailoring tacrolimus therapy in kidney transplantation. Expert Rev Clin Pharmacol. 2018;11:581–8. http://www.ncbi.nlm.nih.gov/pubmed/29779413.
3. United States Renal Data System. 2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. https://adr.usrds.org/2023.
4. Taber DJ, Egede LE, Baliga PK. Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg. 2017;213:666–72. http://www.ncbi.nlm.nih.gov/pubmed/27887677.
5. Fan PY, Ashby VB, Fuller DS, Boulware LE, Kao A, Norman SP, et al. Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant. 2010;10:1090–107. http://www.ncbi.nlm.nih.gov/pubmed/20420655.